News
Business Results Q1 of 2017
Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016 For the quarter ended March 31, 2017, versus the quarter ended March 31, 2016, Cosmos Holdings’ revenue improved 262% to $4.1 million from $1.1 million on the strength of its SkyPharm SA subsidiary, which obtained the necessary capital during 2016 and 2017 in order to develop, expand and organically grow its operations. Of note, revenue improved sequentially 27%, from $3.2 million in the 2016 ...
Cosmos Holdings, Inc. Announces first Quarter 2017 Results
Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016 For the quarter ended March 31, 2017, versus the quarter ended March 31, 2016, Cosmos Holdings' revenue improved 262% to $4.1 million from $1.1 million on the strength of its SkyPharm SA subsidiary, which obtained the necessary capital during 2016 and 2017 in order to develop, expand and organically grow its operations. Of note, revenue improved sequentially 27%, from $3.2 million in the 2016 ...
Business Results Q4 of 2016
Cosmos Holdings Inc. reported strong revenue growth in the fourth quarter of 2016 over the previous quarter. Sales increased from $1,414,000 to $3,070,000 from Q3 2016 to Q4 2016, respectively, an over 110% improvement. The increase was due to organic growth in sales from the Company’s subsidiary Sky Pharm SA. Cosmos Holdings had revenue for the full year ended December 31, 2016, of $6,755,436, versus $533,802 for the full year ended December 31, 2015. During 2016, revenues increased over ...
Cosmos Holdings, Inc. Acquires Decahedron Ltd
CHICAGO, IL - (Marketwired - Feb 14, 2017) - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that the Company acquired 100% of the shares of Decahedron Ltd, a privately held company located in Harlow, United Kingdom just north of London. Decahedron Ltd. is a pharmaceutical wholesaler incorporated in the UK in August 2011 and it is audited by the MHRA (Medicines and Healthcare Products Regulatory Agency) under European GDP (Good Distribution Practices). Decahedron is ...
Cosmos Holdings, Inc. Establishes its Advisory Board and Adds Orestes Varvitsiotes as its Initial Member
Cosmos Holdings, Inc., announced that Orestes Varvitsiotes has been appointed as the initial board member of its Advisory Board of Directors. Mr. Varvitsiotes is currently working with Aegis Capital Corp. in New York. He is a wealth management professional with more than 25 years of experience in the capital markets. His experience extends in various fields of the financial industry such as financial consulting, portfolio management, trading and capital raising. Cosmos Holdings CEO Gregory Siokas commented, "As the company grows we ...
Photo
Steve Carr Managing Director

Join our mailing list to stay up to date.

Cosmos-logo